Numbers
The Numbers
DAQO trades at $19.22 — roughly 0.29x book value — because the market sees a commodity producer with negative margins, massive industry overcapacity, and uncertain policy rescue. The stock price is almost entirely a function of the $29/share in net cash; the operating business is being valued near zero. The single metric that would rerate this stock is gross margin turning positive on a sustained basis, which requires polysilicon ASP rising above ~$7/kg or utilization climbing past 80%.
Current Price
Market Cap ($M)
Book Value / Share
Net Cash / Share
Quality Score, Fair Value, and Predictability data are not available for this company in the current dataset. Analysis relies on reported financials and valuation ratios.
Revenue and Earnings Power
Revenue collapsed 86% from peak ($4.6B in FY2022) to $665M in FY2025 — driven entirely by polysilicon price, not volume. The company went from $1.8B net income to a $171M loss in three years, illustrating why commodity producers should never be valued on peak earnings.
Q3-Q4 FY2025 showed green shoots — gross margins turned slightly positive (4% and 7%) as costs fell and ASP stabilized. Q1 FY2026 then collapsed to $27M revenue as DAQO deliberately withheld sales volume, waiting for government price guidance.
Cash Generation — Are the Earnings Real?
In profitable years (2020-2023), operating cash flow consistently exceeded net income — healthy conversion. FY2022 stands out: $2.5B operating CF on $1.8B net income, reflecting massive working capital inflows as receivables were collected. FY2025 showed a critical inflection: operating cash flow turned positive ($50M) even as the company reported a $171M net loss — driven by non-cash depreciation ($240M) and SBC ($56M) exceeding the loss.
Cumulative capex from 2021-2025 totaled $3.3B — primarily building the Inner Mongolia facility. That investment cycle is now winding down (FY2026 capex guided at $100-150M), meaning FCF should improve sharply even at current depressed revenue levels.
Capital Allocation
DAQO returned $616M through buybacks in FY2022-2024, reducing shares from 78M to 67M ADS (14% reduction). No dividends have ever been paid. SBC is significant — $56M in FY2025 on $665M revenue (8.4% of sales) — diluting the buyback benefit. The company has suspended buybacks during the downturn, preserving cash.
Balance Sheet Health
Current Ratio
Debt / Equity
Net Cash ($M)
Book Equity ($M)
The balance sheet is the single strongest aspect of this company. Zero debt since FY2021. Current ratio of 5.4x. Net cash of $1.9B represents 150% of market cap. Even if the company burned $50M/quarter indefinitely, the cash runway exceeds 9 years. This balance sheet is the reason DAQO can play the attrition game.
Valuation — Historical Context
P/B ratio is the only meaningful valuation metric when earnings are negative. At 0.45x book, DAQO trades at a fraction of book value — implying the market expects significant book value destruction ahead (asset impairments, continued losses) or doubts the realizable value of Chinese-domiciled assets.
P/B (Current)
P/B (5Y Median)
P/B (Trough - FY2024)
At 0.45x book, the stock is near the lower bound of its historical range (trough 0.30x in FY2024). The 5-year median of 1.4x P/B implies ~3x upside if the business normalizes — but that median includes the boom years of 2020-2022 when margins were extraordinary.
Per-Share Economics
Book value per share has been remarkably stable at $63-66 through FY2023-2025 despite two years of losses — reflecting the large accumulated equity base from the boom years. The 14% share count reduction from buybacks partially offset losses.
Peer Comparison
DAQO's key peer advantage: zero debt and $1.9B net cash. GCL and Tongwei carry significant debt into the downturn. Wacker and OCI remain profitable because they serve non-Chinese markets with tariff protection and semiconductor demand. The P/B discount to Wacker (0.45x vs 1.5x) reflects both China risk and the loss-making status.
Fair Value and Scenario Analysis
Analyst consensus target is ~$25 (range $14-$41), reflecting deep uncertainty. The bear-to-bull range is 3.7x, unusually wide, because outcomes are almost entirely policy-dependent rather than operationally driven.
The numbers confirm DAQO's fortress balance sheet and cost leadership — the two attributes that matter most in a commodity trough. What the numbers contradict is any narrative of imminent recovery: Q1 FY2026 revenue of $27M (annualized run rate of ~$107M against $665M trailing) shows the business is still deteriorating operationally even as Q4 FY2025 flashed early recovery signals. Watch quarterly gross margin: if it sustains positive territory for two consecutive quarters at utilization above 60%, the stock rerates sharply — every 10 percentage points of gross margin improvement at normalized volume adds roughly $5/share in annual earnings power.